Armstrong Advisory Group’s Gilead Sciences GILD Stock Holding History

Armstrong Advisory Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$203K	Hold	1,606	–	–	0.01%	243
2026 Q1	$224K	Hold	1,606	–	–	0.02%	226
2025 Q4	$197K	Hold	1,606	–	–	0.01%	226
2025 Q3	$178K	Hold	1,606	–	–	0.01%	229
2025 Q2	$178K	Hold	1,606	–	–	0.01%	219
2025 Q1	$148K	Hold	1,606	–	–	0.01%	224
2024 Q4	$148K	Buy	1,606 +200	+14%	+$18K	0.01%	224
2024 Q3	$118K	Hold	1,406	–	–	0.01%	252
2024 Q2	$96.5K	Hold	1,406	–	–	0.01%	264
2024 Q1	$114K	Hold	1,406	–	–	0.01%	235
2023 Q4	$114K	Sell	1,406 -44	-3%	-$3.42K	0.01%	235
2023 Q3	$109K	Buy	1,450 +144	+11%	+$11.1K	0.01%	223
2023 Q2	$101K	Sell	1,306 -846	-39%	-$67.5K	0.01%	235
2023 Q1	$179K	Hold	2,152	–	–	0.02%	177
2022 Q4	$185K	Buy	+2,152	New	+$170K	0.02%	171

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Armstrong Advisory Group's GILD Position: Q2 2026 in Review

Armstrong Advisory Group held its Gilead Sciences (GILD) position steady in Q2 2026 at 1,606 shares worth $203K. The position accounts for 0.01% of the portfolio, ranked #243.

Armstrong Advisory Group first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $224K in Q1 2026. 485 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Armstrong Advisory Group held 1,606 shares of Gilead Sciences worth $203K as of Q2 2026.
Armstrong Advisory Group left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #243 holding.
Armstrong Advisory Group first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
Armstrong Advisory Group's Gilead Sciences position peaked at $224K in Q1 2026.
485 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.